# Canine geroscience evidence > Source-linked, model-free evidence pages on aging research in companion dogs, generated from the dog-geroscience-mcp database. Every figure is shown with its verbatim quote and identifier (PMID, foi_id, NADA). Text CC BY 4.0; data per source. ## Sections - [Interventions](https://w0lph.github.io/k9/interventions/index.html): the dog evidence for every NIA ITP compound - [FDA FOI summaries by ingredient](https://w0lph.github.io/k9/fda-foi/index.html): dose, PK, safety and effectiveness data from FDA CVM reviews of dog products ## Interventions - [(R/S)-1,3-butanediol](https://w0lph.github.io/k9/interventions/r-s-1-3-butanediol.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [16-alpha-hydroxyestradiol](https://w0lph.github.io/k9/interventions/16-alpha-hydroxyestradiol.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride](https://w0lph.github.io/k9/interventions/17-dimethylaminoethylamino-17-demethoxygeldanamycin-hydrochloride.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [17‐alpha‐estradiol](https://w0lph.github.io/k9/interventions/17-alpha-estradiol.html): 6 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [2,4-dinitrophenol](https://w0lph.github.io/k9/interventions/2-4-dinitrophenol.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [2-(2-hydroxyphenyl)benzothiazole](https://w0lph.github.io/k9/interventions/2-2-hydroxyphenyl-benzothiazole.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [4-hydroxyphenyl-N-tert-butylnitrone](https://w0lph.github.io/k9/interventions/4-hydroxyphenyl-n-tert-butylnitrone.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [4-phenylbutyrate](https://w0lph.github.io/k9/interventions/4-phenylbutyrate.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Acarbose](https://w0lph.github.io/k9/interventions/acarbose.html): 10 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Alpha-ketoglutarate](https://w0lph.github.io/k9/interventions/alpha-ketoglutarate.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Aspirin](https://w0lph.github.io/k9/interventions/aspirin.html): 6 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [Astaxanthin](https://w0lph.github.io/k9/interventions/astaxanthin.html): 2 ITP rows, 0 dog lifespan rows, 6 canine papers, 0 FDA FOI summaries - [Beta-guanidinopropionic acid](https://w0lph.github.io/k9/interventions/beta-guanidinopropionic-acid.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Caffeic acid phenethylester](https://w0lph.github.io/k9/interventions/caffeic-acid-phenethylester.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Canagliflozin](https://w0lph.github.io/k9/interventions/canagliflozin.html): 6 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [Candesartan cilexetil](https://w0lph.github.io/k9/interventions/candesartan-cilexetil.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Captopril](https://w0lph.github.io/k9/interventions/captopril.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Curcumin](https://w0lph.github.io/k9/interventions/curcumin.html): 2 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [Dimethyl fumarate](https://w0lph.github.io/k9/interventions/dimethyl-fumarate.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Enalapril](https://w0lph.github.io/k9/interventions/enalapril.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Fisetin](https://w0lph.github.io/k9/interventions/fisetin.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Fish oil](https://w0lph.github.io/k9/interventions/fish-oil.html): 4 ITP rows, 0 dog lifespan rows, 13 canine papers, 0 FDA FOI summaries - [Geranylgeranylacetone](https://w0lph.github.io/k9/interventions/geranylgeranylacetone.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Glycine](https://w0lph.github.io/k9/interventions/glycine.html): 2 ITP rows, 0 dog lifespan rows, 12 canine papers, 0 FDA FOI summaries - [Green tea extract](https://w0lph.github.io/k9/interventions/green-tea-extract.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Hydralazine](https://w0lph.github.io/k9/interventions/hydralazine.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [INT-767d (FXR/TGR5 agonist)](https://w0lph.github.io/k9/interventions/int-767d-fxr-tgr5-agonist.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Inulin](https://w0lph.github.io/k9/interventions/inulin.html): 2 ITP rows, 0 dog lifespan rows, 5 canine papers, 0 FDA FOI summaries - [Leucine](https://w0lph.github.io/k9/interventions/leucine.html): 2 ITP rows, 0 dog lifespan rows, 11 canine papers, 0 FDA FOI summaries - [MIF098 (CD74 antagonist)](https://w0lph.github.io/k9/interventions/mif098-cd74-antagonist.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Meclizine](https://w0lph.github.io/k9/interventions/meclizine.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Medium-chain triglyceride oil](https://w0lph.github.io/k9/interventions/medium-chain-triglyceride-oil.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Metformin](https://w0lph.github.io/k9/interventions/metformin.html): 2 ITP rows, 0 dog lifespan rows, 8 canine papers, 0 FDA FOI summaries - [Methylene blue](https://w0lph.github.io/k9/interventions/methylene-blue.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Minocycline](https://w0lph.github.io/k9/interventions/minocycline.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [MitoQ](https://w0lph.github.io/k9/interventions/mitoq.html): 2 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [Mycophenolic acid](https://w0lph.github.io/k9/interventions/mycophenolic-acid.html): 2 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [Nebivolol](https://w0lph.github.io/k9/interventions/nebivolol.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Nicotinamide riboside](https://w0lph.github.io/k9/interventions/nicotinamide-riboside.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Nitroflurbiprofen](https://w0lph.github.io/k9/interventions/nitroflurbiprofen.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Nordihydroguaiaretic acid](https://w0lph.github.io/k9/interventions/nordihydroguaiaretic-acid.html): 6 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Oxaloacetate](https://w0lph.github.io/k9/interventions/oxaloacetate.html): 2 ITP rows, 0 dog lifespan rows, 2 canine papers, 0 FDA FOI summaries - [PB125 (carnosol, withaferin A and luteolin)](https://w0lph.github.io/k9/interventions/pb125-carnosol-withaferin-a-and-luteolin.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Protandim](https://w0lph.github.io/k9/interventions/protandim.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Rapamycin](https://w0lph.github.io/k9/interventions/rapamycin.html): 16 ITP rows, 0 dog lifespan rows, 152 canine papers, 0 FDA FOI summaries - [Resveratrol](https://w0lph.github.io/k9/interventions/resveratrol.html): 6 ITP rows, 0 dog lifespan rows, 3 canine papers, 0 FDA FOI summaries - [SG1002 (hydrogen sulfide donor)](https://w0lph.github.io/k9/interventions/sg1002-hydrogen-sulfide-donor.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Simvastatin](https://w0lph.github.io/k9/interventions/simvastatin.html): 4 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Sodium thiosulfate](https://w0lph.github.io/k9/interventions/sodium-thiosulfate.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Sulindac](https://w0lph.github.io/k9/interventions/sulindac.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Syringaresinol](https://w0lph.github.io/k9/interventions/syringaresinol.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [TM5441 (PAI-1 inhibitor)](https://w0lph.github.io/k9/interventions/tm5441-pai-1-inhibitor.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Ursodeoxycholic acid](https://w0lph.github.io/k9/interventions/ursodeoxycholic-acid.html): 2 ITP rows, 0 dog lifespan rows, 0 canine papers, 0 FDA FOI summaries - [Ursolic acid](https://w0lph.github.io/k9/interventions/ursolic-acid.html): 2 ITP rows, 0 dog lifespan rows, 1 canine papers, 0 FDA FOI summaries - [Selegiline](https://w0lph.github.io/k9/interventions/selegiline.html): 0 ITP rows, 1 dog lifespan rows, 19 canine papers, 2 FDA FOI summaries - [Carprofen](https://w0lph.github.io/k9/interventions/carprofen.html): 0 ITP rows, 0 dog lifespan rows, 1 canine papers, 11 FDA FOI summaries ## FDA FOI summaries by ingredient - [(S)-Methoprene](https://w0lph.github.io/k9/fda-foi/s-methoprene.html): 1 summaries, 0 PK values, 4 adverse-reaction rows - [Acepromazine Maleate](https://w0lph.github.io/k9/fda-foi/acepromazine-maleate.html): 3 summaries, 6 PK values, 1 adverse-reaction rows - [Afoxolaner](https://w0lph.github.io/k9/fda-foi/afoxolaner.html): 7 summaries, 6 PK values, 19 adverse-reaction rows - [Afoxolaner, Moxidectin, Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/afoxolaner-moxidectin-pyrantel-pamoate.html): 4 summaries, 0 PK values, 10 adverse-reaction rows - [Alfaxalone](https://w0lph.github.io/k9/fda-foi/alfaxalone.html): 3 summaries, 8 PK values, 8 adverse-reaction rows - [Amikacin Sulfate](https://w0lph.github.io/k9/fda-foi/amikacin-sulfate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Amoxicillin Trihydrate, Clavulanate Potassium](https://w0lph.github.io/k9/fda-foi/amoxicillin-trihydrate-clavulanate-potassium.html): 9 summaries, 46 PK values, 0 adverse-reaction rows - [Amoxicillin, Clavulanate Potassium](https://w0lph.github.io/k9/fda-foi/amoxicillin-clavulanate-potassium.html): 1 summaries, 8 PK values, 0 adverse-reaction rows - [Ampicillin Trihydrate](https://w0lph.github.io/k9/fda-foi/ampicillin-trihydrate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Atinvicitinib](https://w0lph.github.io/k9/fda-foi/atinvicitinib.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [Atipamezole Hydrochloride](https://w0lph.github.io/k9/fda-foi/atipamezole-hydrochloride.html): 6 summaries, 3 PK values, 2 adverse-reaction rows - [Attapulgite, Bismuth Subcarbonate, Kanamycin Sulfate](https://w0lph.github.io/k9/fda-foi/attapulgite-bismuth-subcarbonate-kanamycin-sulfate.html): 1 summaries, 0 PK values, 1 adverse-reaction rows - [Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate](https://w0lph.github.io/k9/fda-foi/bacitracin-zinc-neomycin-sulfate-polymyxin-b-sulfate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Bedinvetmab](https://w0lph.github.io/k9/fda-foi/bedinvetmab.html): 1 summaries, 4 PK values, 6 adverse-reaction rows - [Betamethasone Acetate, Florfenicol, Terbinafine](https://w0lph.github.io/k9/fda-foi/betamethasone-acetate-florfenicol-terbinafine.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Betamethasone Acetate, Gentamicin Sulfate](https://w0lph.github.io/k9/fda-foi/betamethasone-acetate-gentamicin-sulfate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Betamethasone Acetate, Terbinafine](https://w0lph.github.io/k9/fda-foi/betamethasone-acetate-terbinafine.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Betamethasone Valerate, Clotrimazole, Gentamicin Sulfate](https://w0lph.github.io/k9/fda-foi/betamethasone-valerate-clotrimazole-gentamicin-sulfate.html): 7 summaries, 0 PK values, 1 adverse-reaction rows - [Betamethasone Valerate, Gentamicin Sulfate](https://w0lph.github.io/k9/fda-foi/betamethasone-valerate-gentamicin-sulfate.html): 5 summaries, 0 PK values, 0 adverse-reaction rows - [Bupivacaine](https://w0lph.github.io/k9/fda-foi/bupivacaine.html): 2 summaries, 8 PK values, 12 adverse-reaction rows - [Capromorelin](https://w0lph.github.io/k9/fda-foi/capromorelin.html): 1 summaries, 5 PK values, 6 adverse-reaction rows - [Carprofen](https://w0lph.github.io/k9/fda-foi/carprofen.html): 30 summaries, 87 PK values, 32 adverse-reaction rows - [Cefadroxil](https://w0lph.github.io/k9/fda-foi/cefadroxil.html): 1 summaries, 8 PK values, 3 adverse-reaction rows - [Cefovecin sodium](https://w0lph.github.io/k9/fda-foi/cefovecin-sodium.html): 2 summaries, 8 PK values, 6 adverse-reaction rows - [Cefpodoxime proxetil](https://w0lph.github.io/k9/fda-foi/cefpodoxime-proxetil.html): 4 summaries, 22 PK values, 6 adverse-reaction rows - [Ceftiofur Sodium](https://w0lph.github.io/k9/fda-foi/ceftiofur-sodium.html): 16 summaries, 27 PK values, 8 adverse-reaction rows - [Cephalexin](https://w0lph.github.io/k9/fda-foi/cephalexin.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [Chlorhexidine Acetate](https://w0lph.github.io/k9/fda-foi/chlorhexidine-acetate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Chloroquine Phosphate, Embutramide, Lidocaine](https://w0lph.github.io/k9/fda-foi/chloroquine-phosphate-embutramide-lidocaine.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Clindamycin](https://w0lph.github.io/k9/fda-foi/clindamycin.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Clindamycin Hydrochloride](https://w0lph.github.io/k9/fda-foi/clindamycin-hydrochloride.html): 14 summaries, 18 PK values, 2 adverse-reaction rows - [Clomipramine Hydrochloride](https://w0lph.github.io/k9/fda-foi/clomipramine-hydrochloride.html): 4 summaries, 10 PK values, 6 adverse-reaction rows - [Clotrimazole, Gentamicin Sulfate, Mometasone furoate](https://w0lph.github.io/k9/fda-foi/clotrimazole-gentamicin-sulfate-mometasone-furoate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Clotrimazole, Gentamicin Sulfate, Mometasone Furoate Monohydrate](https://w0lph.github.io/k9/fda-foi/clotrimazole-gentamicin-sulfate-mometasone-furoate-monohydrate.html): 3 summaries, 1 PK values, 6 adverse-reaction rows - [Corticotropin](https://w0lph.github.io/k9/fda-foi/corticotropin.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Cosyntropin](https://w0lph.github.io/k9/fda-foi/cosyntropin.html): 1 summaries, 0 PK values, 3 adverse-reaction rows - [Crofelemer](https://w0lph.github.io/k9/fda-foi/crofelemer.html): 1 summaries, 3 PK values, 6 adverse-reaction rows - [Cyclosporine](https://w0lph.github.io/k9/fda-foi/cyclosporine.html): 5 summaries, 8 PK values, 9 adverse-reaction rows - [Cythioate](https://w0lph.github.io/k9/fda-foi/cythioate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Deracoxib](https://w0lph.github.io/k9/fda-foi/deracoxib.html): 7 summaries, 9 PK values, 19 adverse-reaction rows - [Desoxycorticosterone Pivalate](https://w0lph.github.io/k9/fda-foi/desoxycorticosterone-pivalate.html): 2 summaries, 7 PK values, 12 adverse-reaction rows - [Dexamethasone](https://w0lph.github.io/k9/fda-foi/dexamethasone.html): 2 summaries, 0 PK values, 0 adverse-reaction rows - [Dexamethasone, Marbofloxacin, Terbinafine](https://w0lph.github.io/k9/fda-foi/dexamethasone-marbofloxacin-terbinafine.html): 1 summaries, 1 PK values, 4 adverse-reaction rows - [Dexamethasone, Neomycin Sulfate, Thiabendazole](https://w0lph.github.io/k9/fda-foi/dexamethasone-neomycin-sulfate-thiabendazole.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Dexmedetomidine](https://w0lph.github.io/k9/fda-foi/dexmedetomidine.html): 1 summaries, 2 PK values, 5 adverse-reaction rows - [Dexmedetomidine hydrochloride](https://w0lph.github.io/k9/fda-foi/dexmedetomidine-hydrochloride.html): 8 summaries, 0 PK values, 18 adverse-reaction rows - [Diazepam](https://w0lph.github.io/k9/fda-foi/diazepam.html): 1 summaries, 0 PK values, 1 adverse-reaction rows - [Dichlorvos](https://w0lph.github.io/k9/fda-foi/dichlorvos.html): 1 summaries, 0 PK values, 1 adverse-reaction rows - [Diethylcarbamazine Citrate, Oxibendazole](https://w0lph.github.io/k9/fda-foi/diethylcarbamazine-citrate-oxibendazole.html): 1 summaries, 0 PK values, 1 adverse-reaction rows - [Difloxacin Hydrochloride](https://w0lph.github.io/k9/fda-foi/difloxacin-hydrochloride.html): 1 summaries, 8 PK values, 1 adverse-reaction rows - [Dirlotapide](https://w0lph.github.io/k9/fda-foi/dirlotapide.html): 1 summaries, 5 PK values, 6 adverse-reaction rows - [Doxapram Hydrochloride](https://w0lph.github.io/k9/fda-foi/doxapram-hydrochloride.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Doxycycline Hyclate](https://w0lph.github.io/k9/fda-foi/doxycycline-hyclate.html): 1 summaries, 3 PK values, 1 adverse-reaction rows - [Enrofloxacin](https://w0lph.github.io/k9/fda-foi/enrofloxacin.html): 21 summaries, 80 PK values, 19 adverse-reaction rows - [Enrofloxacin, Silver sulfadiazine](https://w0lph.github.io/k9/fda-foi/enrofloxacin-silver-sulfadiazine.html): 2 summaries, 0 PK values, 1 adverse-reaction rows - [Epsiprantel](https://w0lph.github.io/k9/fda-foi/epsiprantel.html): 1 summaries, 0 PK values, 2 adverse-reaction rows - [Erythromycin](https://w0lph.github.io/k9/fda-foi/erythromycin.html): 1 summaries, 1 PK values, 1 adverse-reaction rows - [estriol](https://w0lph.github.io/k9/fda-foi/estriol.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [Etodolac](https://w0lph.github.io/k9/fda-foi/etodolac.html): 3 summaries, 16 PK values, 8 adverse-reaction rows - [Febantel](https://w0lph.github.io/k9/fda-foi/febantel.html): 1 summaries, 0 PK values, 2 adverse-reaction rows - [Febantel, Praziquantel](https://w0lph.github.io/k9/fda-foi/febantel-praziquantel.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Febantel, Praziquantel, Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/febantel-praziquantel-pyrantel-pamoate.html): 4 summaries, 0 PK values, 6 adverse-reaction rows - [Fenbendazole](https://w0lph.github.io/k9/fda-foi/fenbendazole.html): 2 summaries, 0 PK values, 2 adverse-reaction rows - [Fenbendazole, Ivermectin, Praziquantel](https://w0lph.github.io/k9/fda-foi/fenbendazole-ivermectin-praziquantel.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Fentanyl](https://w0lph.github.io/k9/fda-foi/fentanyl.html): 1 summaries, 6 PK values, 6 adverse-reaction rows - [firocoxib](https://w0lph.github.io/k9/fda-foi/firocoxib.html): 8 summaries, 19 PK values, 20 adverse-reaction rows - [Florfenicol, Mometasone furoate, Terbinafine](https://w0lph.github.io/k9/fda-foi/florfenicol-mometasone-furoate-terbinafine.html): 4 summaries, 0 PK values, 6 adverse-reaction rows - [Flumethasone](https://w0lph.github.io/k9/fda-foi/flumethasone.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Fluoxetine hydrochloride](https://w0lph.github.io/k9/fda-foi/fluoxetine-hydrochloride.html): 1 summaries, 10 PK values, 6 adverse-reaction rows - [Fluralaner](https://w0lph.github.io/k9/fda-foi/fluralaner.html): 9 summaries, 18 PK values, 28 adverse-reaction rows - [Fomepizole](https://w0lph.github.io/k9/fda-foi/fomepizole.html): 1 summaries, 4 PK values, 1 adverse-reaction rows - [Furosemide](https://w0lph.github.io/k9/fda-foi/furosemide.html): 4 summaries, 6 PK values, 1 adverse-reaction rows - [Fuzapladib sodium](https://w0lph.github.io/k9/fda-foi/fuzapladib-sodium.html): 1 summaries, 7 PK values, 6 adverse-reaction rows - [Gentamicin Sulfate](https://w0lph.github.io/k9/fda-foi/gentamicin-sulfate.html): 2 summaries, 0 PK values, 0 adverse-reaction rows - [Gentamicin Sulfate, Hydrocortisone aceponate, Miconazole Nitrate](https://w0lph.github.io/k9/fda-foi/gentamicin-sulfate-hydrocortisone-aceponate-miconazole-nitrate.html): 1 summaries, 2 PK values, 1 adverse-reaction rows - [Gentamicin, Mometasone furoate, posaconazole](https://w0lph.github.io/k9/fda-foi/gentamicin-mometasone-furoate-posaconazole.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Glycopyrrolate](https://w0lph.github.io/k9/fda-foi/glycopyrrolate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Grapiprant](https://w0lph.github.io/k9/fda-foi/grapiprant.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [Halothane](https://w0lph.github.io/k9/fda-foi/halothane.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Hemoglobin Glutamer-200 (bovine)](https://w0lph.github.io/k9/fda-foi/hemoglobin-glutamer-200-bovine.html): 2 summaries, 3 PK values, 6 adverse-reaction rows - [Ilunocitinib](https://w0lph.github.io/k9/fda-foi/ilunocitinib.html): 2 summaries, 8 PK values, 6 adverse-reaction rows - [Imepitoin](https://w0lph.github.io/k9/fda-foi/imepitoin.html): 1 summaries, 9 PK values, 6 adverse-reaction rows - [Imidacloprid](https://w0lph.github.io/k9/fda-foi/imidacloprid.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Imidacloprid, Ivermectin](https://w0lph.github.io/k9/fda-foi/imidacloprid-ivermectin.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Imidacloprid, Moxidectin](https://w0lph.github.io/k9/fda-foi/imidacloprid-moxidectin.html): 7 summaries, 7 PK values, 12 adverse-reaction rows - [Imidocarb Dipropionate](https://w0lph.github.io/k9/fda-foi/imidocarb-dipropionate.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Insulin (protamine zinc recombinant human insulin)](https://w0lph.github.io/k9/fda-foi/insulin-protamine-zinc-recombinant-human-insulin.html): 2 summaries, 8 PK values, 12 adverse-reaction rows - [Isoflurane](https://w0lph.github.io/k9/fda-foi/isoflurane.html): 6 summaries, 0 PK values, 0 adverse-reaction rows - [Ivermectin](https://w0lph.github.io/k9/fda-foi/ivermectin.html): 9 summaries, 4 PK values, 7 adverse-reaction rows - [Ivermectin, Praziquantel, Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/ivermectin-praziquantel-pyrantel-pamoate.html): 3 summaries, 8 PK values, 7 adverse-reaction rows - [Ivermectin, Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/ivermectin-pyrantel-pamoate.html): 4 summaries, 4 PK values, 4 adverse-reaction rows - [Levothyroxine sodium](https://w0lph.github.io/k9/fda-foi/levothyroxine-sodium.html): 2 summaries, 9 PK values, 12 adverse-reaction rows - [Lincomycin Hydrochloride Monohydrate](https://w0lph.github.io/k9/fda-foi/lincomycin-hydrochloride-monohydrate.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Lotilaner](https://w0lph.github.io/k9/fda-foi/lotilaner.html): 3 summaries, 6 PK values, 9 adverse-reaction rows - [Lotilaner, Moxidectin, Praziquantel, Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/lotilaner-moxidectin-praziquantel-pyrantel-pamoate.html): 4 summaries, 8 PK values, 15 adverse-reaction rows - [Lufenuron](https://w0lph.github.io/k9/fda-foi/lufenuron.html): 5 summaries, 2 PK values, 5 adverse-reaction rows - [Lufenuron, Milbemycin Oxime](https://w0lph.github.io/k9/fda-foi/lufenuron-milbemycin-oxime.html): 3 summaries, 0 PK values, 6 adverse-reaction rows - [Lufenuron, Milbemycin Oxime, Nitenpyram](https://w0lph.github.io/k9/fda-foi/lufenuron-milbemycin-oxime-nitenpyram.html): 1 summaries, 0 PK values, 3 adverse-reaction rows - [Lufenuron, Milbemycin Oxime, Praziquantel](https://w0lph.github.io/k9/fda-foi/lufenuron-milbemycin-oxime-praziquantel.html): 2 summaries, 4 PK values, 7 adverse-reaction rows - [Lufenuron, Nitenpyram](https://w0lph.github.io/k9/fda-foi/lufenuron-nitenpyram.html): 1 summaries, 0 PK values, 5 adverse-reaction rows - [Marbofloxacin](https://w0lph.github.io/k9/fda-foi/marbofloxacin.html): 5 summaries, 31 PK values, 13 adverse-reaction rows - [Maropitant](https://w0lph.github.io/k9/fda-foi/maropitant.html): 5 summaries, 9 PK values, 12 adverse-reaction rows - [Maropitant citrate](https://w0lph.github.io/k9/fda-foi/maropitant-citrate.html): 5 summaries, 23 PK values, 9 adverse-reaction rows - [Medetomidine hydrochloride](https://w0lph.github.io/k9/fda-foi/medetomidine-hydrochloride.html): 2 summaries, 0 PK values, 3 adverse-reaction rows - [Medetomidine hydrochloride and vatinoxan hydrochloride](https://w0lph.github.io/k9/fda-foi/medetomidine-hydrochloride-and-vatinoxan-hydrochloride.html): 1 summaries, 5 PK values, 6 adverse-reaction rows - [Melarsomine dihydrochloride](https://w0lph.github.io/k9/fda-foi/melarsomine-dihydrochloride.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [meloxicam](https://w0lph.github.io/k9/fda-foi/meloxicam.html): 17 summaries, 58 PK values, 21 adverse-reaction rows - [Metronidazole](https://w0lph.github.io/k9/fda-foi/metronidazole.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Miconazole Nitrate](https://w0lph.github.io/k9/fda-foi/miconazole-nitrate.html): 2 summaries, 0 PK values, 0 adverse-reaction rows - [Miconazole Nitrate, Polymyxin B Sulfate, Prednisolone Acetate](https://w0lph.github.io/k9/fda-foi/miconazole-nitrate-polymyxin-b-sulfate-prednisolone-acetate.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Milbemycin Oxime](https://w0lph.github.io/k9/fda-foi/milbemycin-oxime.html): 7 summaries, 8 PK values, 11 adverse-reaction rows - [Milbemycin oxime/praziquantel](https://w0lph.github.io/k9/fda-foi/milbemycin-oxime-praziquantel.html): 2 summaries, 4 PK values, 2 adverse-reaction rows - [Moxidectin](https://w0lph.github.io/k9/fda-foi/moxidectin.html): 6 summaries, 9 PK values, 13 adverse-reaction rows - [Mupirocin](https://w0lph.github.io/k9/fda-foi/mupirocin.html): 4 summaries, 0 PK values, 0 adverse-reaction rows - [Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide](https://w0lph.github.io/k9/fda-foi/neomycin-sulfate-nystatin-thiostrepton-triamcinolone-acetonide.html): 5 summaries, 0 PK values, 0 adverse-reaction rows - [Nitenpyram](https://w0lph.github.io/k9/fda-foi/nitenpyram.html): 3 summaries, 14 PK values, 1 adverse-reaction rows - [Nitrofurazone](https://w0lph.github.io/k9/fda-foi/nitrofurazone.html): 3 summaries, 0 PK values, 0 adverse-reaction rows - [Oclacitinib](https://w0lph.github.io/k9/fda-foi/oclacitinib.html): 2 summaries, 16 PK values, 9 adverse-reaction rows - [Orbifloxacin](https://w0lph.github.io/k9/fda-foi/orbifloxacin.html): 4 summaries, 23 PK values, 5 adverse-reaction rows - [Orbifloxacin, mometasone furoate monohydrate and posaconazole](https://w0lph.github.io/k9/fda-foi/orbifloxacin-mometasone-furoate-monohydrate-and-posaconazole.html): 1 summaries, 1 PK values, 1 adverse-reaction rows - [Ormetoprim, Sulfadimethoxine](https://w0lph.github.io/k9/fda-foi/ormetoprim-sulfadimethoxine.html): 2 summaries, 2 PK values, 3 adverse-reaction rows - [Pentobarbital Sodium, Phenytoin Sodium](https://w0lph.github.io/k9/fda-foi/pentobarbital-sodium-phenytoin-sodium.html): 3 summaries, 0 PK values, 0 adverse-reaction rows - [Phenobarbital](https://w0lph.github.io/k9/fda-foi/phenobarbital.html): 1 summaries, 2 PK values, 3 adverse-reaction rows - [Phenylbutazone](https://w0lph.github.io/k9/fda-foi/phenylbutazone.html): 1 summaries, 0 PK values, 0 adverse-reaction rows - [Phenylpropanolamine hydrochloride](https://w0lph.github.io/k9/fda-foi/phenylpropanolamine-hydrochloride.html): 3 summaries, 9 PK values, 13 adverse-reaction rows - [Pimobendan](https://w0lph.github.io/k9/fda-foi/pimobendan.html): 6 summaries, 17 PK values, 15 adverse-reaction rows - [Polysulfated Glycosaminoglycan](https://w0lph.github.io/k9/fda-foi/polysulfated-glycosaminoglycan.html): 1 summaries, 4 PK values, 3 adverse-reaction rows - [Porcine insulin zinc suspension](https://w0lph.github.io/k9/fda-foi/porcine-insulin-zinc-suspension.html): 4 summaries, 10 PK values, 18 adverse-reaction rows - [Potassium bromide](https://w0lph.github.io/k9/fda-foi/potassium-bromide.html): 2 summaries, 6 PK values, 10 adverse-reaction rows - [Praziquantel](https://w0lph.github.io/k9/fda-foi/praziquantel.html): 9 summaries, 8 PK values, 4 adverse-reaction rows - [Prednisolone](https://w0lph.github.io/k9/fda-foi/prednisolone.html): 2 summaries, 7 PK values, 1 adverse-reaction rows - [Prednisolone, Trimeprazine Tartrate](https://w0lph.github.io/k9/fda-foi/prednisolone-trimeprazine-tartrate.html): 1 summaries, 8 PK values, 1 adverse-reaction rows - [Pregabalin](https://w0lph.github.io/k9/fda-foi/pregabalin.html): 1 summaries, 1 PK values, 2 adverse-reaction rows - [Propofol](https://w0lph.github.io/k9/fda-foi/propofol.html): 6 summaries, 27 PK values, 30 adverse-reaction rows - [Pyrantel Pamoate](https://w0lph.github.io/k9/fda-foi/pyrantel-pamoate.html): 10 summaries, 2 PK values, 5 adverse-reaction rows - [Pyrantel pamoate / Praziquantel](https://w0lph.github.io/k9/fda-foi/pyrantel-pamoate-praziquantel.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Rabacfosadine](https://w0lph.github.io/k9/fda-foi/rabacfosadine.html): 1 summaries, 4 PK values, 6 adverse-reaction rows - [robenacoxib](https://w0lph.github.io/k9/fda-foi/robenacoxib.html): 4 summaries, 13 PK values, 16 adverse-reaction rows - [Ropinirole](https://w0lph.github.io/k9/fda-foi/ropinirole.html): 1 summaries, 0 PK values, 6 adverse-reaction rows - [Sarolaner](https://w0lph.github.io/k9/fda-foi/sarolaner.html): 4 summaries, 1 PK values, 5 adverse-reaction rows - [Sarolaner, moxidectin, and pyrantel (as pamoate salt)](https://w0lph.github.io/k9/fda-foi/sarolaner-moxidectin-and-pyrantel-as-pamoate-salt.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [Sarolaner, moxidectin, and pyrantel chewable tablets](https://w0lph.github.io/k9/fda-foi/sarolaner-moxidectin-and-pyrantel-chewable-tablets.html): 3 summaries, 0 PK values, 1 adverse-reaction rows - [Selamectin](https://w0lph.github.io/k9/fda-foi/selamectin.html): 8 summaries, 0 PK values, 8 adverse-reaction rows - [Selegiline Hydrochloride](https://w0lph.github.io/k9/fda-foi/selegiline-hydrochloride.html): 2 summaries, 0 PK values, 12 adverse-reaction rows - [Sevoflurane](https://w0lph.github.io/k9/fda-foi/sevoflurane.html): 4 summaries, 7 PK values, 6 adverse-reaction rows - [Spinosad](https://w0lph.github.io/k9/fda-foi/spinosad.html): 2 summaries, 16 PK values, 12 adverse-reaction rows - [Spinosad and milbemycin oxime](https://w0lph.github.io/k9/fda-foi/spinosad-and-milbemycin-oxime.html): 1 summaries, 1 PK values, 6 adverse-reaction rows - [Spironolactone; Benazepril hydrochloride](https://w0lph.github.io/k9/fda-foi/spironolactone-benazepril-hydrochloride.html): 1 summaries, 5 PK values, 6 adverse-reaction rows - [Tasipimidine](https://w0lph.github.io/k9/fda-foi/tasipimidine.html): 1 summaries, 8 PK values, 6 adverse-reaction rows - [tepoxalin](https://w0lph.github.io/k9/fda-foi/tepoxalin.html): 1 summaries, 8 PK values, 5 adverse-reaction rows - [Tigilanol tiglate](https://w0lph.github.io/k9/fda-foi/tigilanol-tiglate.html): 1 summaries, 11 PK values, 6 adverse-reaction rows - [Tiletamine Hydrochloride, Zolazepam Hydrochloride](https://w0lph.github.io/k9/fda-foi/tiletamine-hydrochloride-zolazepam-hydrochloride.html): 5 summaries, 8 PK values, 4 adverse-reaction rows - [Toceranib phosphate](https://w0lph.github.io/k9/fda-foi/toceranib-phosphate.html): 1 summaries, 9 PK values, 7 adverse-reaction rows - [Torsemide](https://w0lph.github.io/k9/fda-foi/torsemide.html): 1 summaries, 8 PK values, 4 adverse-reaction rows - [Triamcinolone Acetonide](https://w0lph.github.io/k9/fda-foi/triamcinolone-acetonide.html): 3 summaries, 4 PK values, 6 adverse-reaction rows - [Trilostane](https://w0lph.github.io/k9/fda-foi/trilostane.html): 2 summaries, 0 PK values, 7 adverse-reaction rows - [Verdinexor](https://w0lph.github.io/k9/fda-foi/verdinexor.html): 2 summaries, 9 PK values, 12 adverse-reaction rows - [Xylazine Hydrochloride](https://w0lph.github.io/k9/fda-foi/xylazine-hydrochloride.html): 5 summaries, 0 PK values, 0 adverse-reaction rows - [Yohimbine hydrochloride](https://w0lph.github.io/k9/fda-foi/yohimbine-hydrochloride.html): 1 summaries, 0 PK values, 2 adverse-reaction rows - [Zinc gluconate neutralized by arginine](https://w0lph.github.io/k9/fda-foi/zinc-gluconate-neutralized-by-arginine.html): 1 summaries, 0 PK values, 6 adverse-reaction rows ## Data and tools - [canine-aging-corpus](https://huggingface.co/datasets/w0lph/canine-aging-corpus) - [foi-summaries-dog](https://huggingface.co/datasets/w0lph/foi-summaries-dog) - [dog-geroscience-mcp-data](https://huggingface.co/datasets/w0lph/dog-geroscience-mcp-data) - [canine-geroscience-questions](https://huggingface.co/datasets/w0lph/canine-geroscience-questions) - [dog-geroscience-mcp source](https://github.com/w0lph/k9/tree/main/mcp)